The EPS projection of Evolent Health Inc (NYSE:EVH) for quarter ended 2016-09-30 is $-0.15. Last week, the EPS forecast was $-0.15 against target of $-0.15, a month earlier. Two months ago, this estimate was $-0.15 versus forecast of $-0.15 three months earlier, implying a deviation of 0%.
Evolent Health Inc (NYSE:EVH) stated that 18 days ago, its stock price was positively revised 1 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 1, 1, and 1, correspondingly.
EPS estimate downgrade for Evolent Health Inc (NYSE:EVH) in the preceding 30, 120, 60 and 90 days were 0, 1, 4, and 3, correspondingly.
Evolent Health Inc (NYSE:EVH) EPS target for the quarter closed 1 was $-0.15, based on 5 recommendations. As reported on 2016-05-12 the EPS was $-0.27. The change was $-0.08, implying a percentage deviation of -42.11%. The projections showed a standard deviation of 0.02.
Quarterly Sales Estimates
Evolent Health Inc (NYSE:EVH) yearly sales prediction for the fiscal 2016 stands at $60.034 and the median estimate is at $60.2. Almost 5 analysts issued sales target.
Highest sales target is $60.4 while the lowest target is $59.1 showing standard deviation of 0.528%.
As many as 5 analysts have sales targets revised upside while 5 reduced sales estimates, implying a deviation of 0%.
Last month, 5 revised sales number projection on upside while 5 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 5 hiked sales target and 5 reduced sales forecast. Evolent Health Inc (NYSE:EVH) announced that the deviation in forecast was -2.17%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...